Lv11
52 积分 2023-08-29 加入
Intravenously administered LV-169 delivers a functional BCMA-CAR transgene to niche-resident T cells and leads to elimination of disseminated myeloma in MHC-deficient NSG mice
4小时前
待确认
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
5天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
8天前
已完结
An inherent T cell-activating mRNA delivery carrier for in vivo CAR T generation
1个月前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors
2个月前
已完结
Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineering
2个月前
已完结
Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineering
2个月前
已完结
Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models
2个月前
已完结
Safe Redosable Low-Immunogenic In Vivo CAR-T Therapy for B Cell Malignancies and Solid Tumors
2个月前
已完结
皖公网安备34019202002308
